$CTSO 8-K SEC Filings

Filed On	Filing
23 Sep 2026	8-K: Regulation FD Disclosure; Other Events PRINCETON, N.J., September 23, 2026 -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that it has regai...
08 Sep 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year CytoSorbents Corporation, a corporation organized and existing by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify:
14 Aug 2026	8-K: Submission of Matters to a Vote of Security Holders
07 Aug 2026	8-K: Regulation FD Disclosure
06 Aug 2026	8-K: Results of Operations and Financial Condition
06 Jul 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
25 Jun 2026	8-K: Regulation FD Disclosure
13 May 2026	8-K: Results of Operations and Financial Condition
02 Apr 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
25 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
13 Nov 2025	8-K: Results of Operations and Financial Condition
03 Oct 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
16 Sep 2025	8-K: Regulation FD Disclosure; Other Events
20 Aug 2025	8-K: Other Events
07 Aug 2025	8-K: Completion of Acquisition or Disposition of Assets
01 Aug 2025	8-K: Other Events
02 Jul 2025	8-K: Other Events
24 Jun 2025	8-K: Other Events
13 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
11 Jun 2025	8-K: Regulation FD Disclosure

Comments